Low molecular weight heparin bridging for atrial fibrillation: Is VTE thromboprophylaxis the major benefit?

Henny H. Billett, Barbara A. Scorziello, Emily R. Giannattasio, Hillel W. Cohen

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Low molecular weight heparin bridging for atrial fibrillation: Is VTE thromboprophylaxis the major benefit?'. Together they form a unique fingerprint.

Medicine & Life Sciences